Inflammatory Blockade Improves Human Pancreatic Islet Function and Viability
Open Access
- 1 March 2005
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 5 (3) , 475-483
- https://doi.org/10.1111/j.1600-6143.2005.00707.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Autoimmune diabetes is blocked in Stat4-deficient miceJournal of Autoimmunity, 2004
- The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation1Transplantation, 2004
- Cell Loss in Isolated Human Islets Occurs by ApoptosisPancreas, 2000
- A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipientsBone Marrow Transplantation, 2000
- Mitochondria and ApoptosisScience, 1998
- Effect of lisofylline and pentoxifylline on the bacterial‐stimulated production of TNF‐α, IL‐1β and IL‐10 by human leucocytesImmunology, 1997
- Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient miceNature, 1996
- Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cellsNature, 1996
- Insulin-Dependent Diabetes MellitusCell, 1996
- CT-1501R SELECTIVELY INHIBITS INDUCED INFLAMMATORY MONOKINES IN HUMAN WHOLE BLOOD EX VIVOShock, 1994